Literature DB >> 2036298

Cerebral and extracranial circulatory disturbances in migraine: pathophysiological implications.

J Olesen1.   

Abstract

Studies of regional cerebral blood flow (rCBF) are rapidly increasing our understanding of migraine mechanisms. In the early phase of an attack, migraine with aura (previously classic migraine) is associated with posterior focal hypoperfusion in one hemisphere. This spreads forward, usually to involve the posterior one-third to one-half of a hemisphere. Hypoperfusion persists into the headache phase and is associated with partial or complete vasoparalysis. From patient to patient, it varies in severity, ranging from almost normal to well below the usual ischemic threshold. After 1 h to several hours, the formerly hypoperfused areas becomes hyperperfused. The headache begins while rCBF is decreased and relates topographically to the area affected by rCBF changes. There is no association with hyperperfusion, which usually begins long after headache onset and often outlasts headache. In migraine without aura, there are no focal rCBF abnormalities but a dispute as to whether flow is globally increased. For a number of reasons, pain mechanisms, however, are likely to be the same as in migraine with aura, just initiated by something else. Extracranial blood flow is unchanged during migraine attacks but the superficial temporal artery on the side of the headache is dilated and recent transcranial Doppler studies have been interesting although difficult to interpret. These results will stimulate further studies of large arteries. The migrainous aura is probably the clinical manifestation of a cortical spreading depression. The resulting ionic and neurotransmitter changes are by way of local irritation of pial perivascular nerves, the most likely mechanism of migraine headache.

Entities:  

Mesh:

Year:  1991        PMID: 2036298

Source DB:  PubMed          Journal:  Cerebrovasc Brain Metab Rev        ISSN: 1040-8827


  19 in total

Review 1.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

Review 2.  Diagnosis and management of migraine.

Authors:  P J Goadsby; J Olesen
Journal:  BMJ       Date:  1996-05-18

Review 3.  Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine.

Authors:  Eric L Moore; Christopher A Salvatore
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

5.  Cerebral blood flow and metabolism in anxiety and anxiety disorders.

Authors:  R J Mathew
Journal:  Indian J Psychiatry       Date:  1994-07       Impact factor: 1.759

6.  Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study.

Authors:  Han Le; Peer Tfelt-Hansen; Axel Skytthe; Kirsten Ohm Kyvik; Jes Olesen
Journal:  J Headache Pain       Date:  2011-03-10       Impact factor: 7.277

7.  Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.

Authors:  Robin James Storer; Simon Akerman; Peter J Goadsby
Journal:  Br J Pharmacol       Date:  2004-07-05       Impact factor: 8.739

Review 8.  Migraine with and without aura share the same pathogenic mechanisms.

Authors:  R Allan Purdy
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

Review 9.  Mechanisms involved in the cerebrovascular dilator effects of cortical spreading depression.

Authors:  David W Busija; Ferenc Bari; Ferenc Domoki; Takashi Horiguchi; Katsuyoshi Shimizu
Journal:  Prog Neurobiol       Date:  2008-09-12       Impact factor: 11.685

Review 10.  The autonomic nervous system and the regulation of arterial tone in migraine.

Authors:  L L Thomsen; J Olesen
Journal:  Clin Auton Res       Date:  1995-10       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.